Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection-Reference-Cited by-同舟云学术

Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection

Published:2007-02-19 Issue:4 Volume:21 Page:441-446
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Bochud Pierre-Yves,Hersberger Martin,Taffé Patrick,Bochud Murielle,Stein Catherine M,Rodrigues Stephanie D,Calandra Thierry,Francioli Patrick,Telenti Amalio,Speck Roberto F,Aderem Alan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference34 articles.

1. Human genes that limit AIDS;O'Brien;Nat Genet,2004

2. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection;Liu;Cell,1996

3. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene;Samson;Nature,1996

4. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene;Dean;Science,1996

5. Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression;Bleiber;J Virol,2005

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Variation in Toll-Like Receptors (TLRs) 2, 4, and 9 Influences HIV Disease Progression Toward Active TB and AIDS;Journal of Inflammation Research;2024-05

2. Host Genetic Impact on Infectious Diseases among Different Ethnic Groups;Advanced Genetics;2023-11-05

3. Role of Toll-like receptor gene polymorphism in pathogenesis of new coronavirus infection;Medical Immunology (Russia);2023-10-17

4. Forecasting most deleterious nsSNPs in human TLR9 gene and their cumulative impact on biophysical features of the protein using in silico approaches;Systems Biology in Reproductive Medicine;2023-01-12

5. Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies;Pathogens;2023-01-05